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The hypolipidemic effect of peroxisome proliferator-activated receptor (PPAR) activators has 
been explained by increasing mitochondrial fatty acid oxidation, as observed in livers of rats 
treated with the pan-PPAR activator tetradecylthioacetic acid (TTA). PPAR-activation does, 
however, not fully explain the metabolic adaptations observed in hepatocytes after treatment 
with TTA. We therefore characterized the mitochondrial effects, and linked this to signalling 
by the metabolic sensor, the mammalian target of rapamycin (mTOR). In hepatocytes isolated 
from TTA-treated rats, the changes in cellular content and morphology were consistent with 
hypertrophy. This was associated with induction of multiple mitochondrial biomarkers, 
including mitochondrial DNA, citrate synthase and mRNAs of mitochondrial proteins. 
Transcription analysis further confirmed activation of PPARα-associated genes, in addition to 
genes related to mitochondrial biogenesis and function. Analysis of mitochondrial respiration 
revealed that the capacity of both electron transport and oxidative phosphorylation were 
increased.  These effects coincided with activation of the stress related factor, ERK1/2, and 
mTOR. The protein level and phosphorylation of the downstream mTOR targets eIF4G and 
4E-BP1 were induced. In summary, TTA increases hepatocyte respiration by inducing 
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Metabolic adaptation is linked to life span regulation [1] and important diseases, such 
as cancer [2], neurodegeneration [3] and obesity-related disorders [4]. Accordingly, 
mechanisms of metabolic adaptation represent potential targets for prevention and treatment 
of disease. 
The peroxisome proliferator-activated receptors (PPARs) [5,6] and the mammalian 
target of rapamycin (mTOR) [7,8] are major regulators of metabolism. They converge on the 
cell survival-associated protein kinase AKT [9], which is involved in insulin signalling and 
metabolic balancing. The PPARs crosstalk with central metabolic sensors, such as AMP-
dependent protein kinase (AMPK) activated upon low energy stress, and PPARγ co-activator 
1α (PGC1α) involved in mitochondrial biogenesis, to control adaptive responses [5,6]. The 
mTOR protein exists in two complexes, named mTOR complex 1/2 (mTORC1/2), where 
mTORC1 is the primary nutrient responder [8].  Upon activation, mTORC1 promotes protein 
translation and cell growth via regulation of the downstream eukaryotic translation initiation 
factor 4E (eIF4E) and the eIF4E-binding protein 1 (4E-BP1) [10].  Upstream regulators of 
mTORC1 includes AKT [11], AMPK [12] and MAP-kinase-extracellular regulated kinase 
(ERK) [13].   
Metabolic signalling is closely associated with regulation of mitochondrial function 
and biogenesis. Mitochondria are essential organelles in cellular energy metabolism, and 
house several catabolic pathways, including fatty acid oxidation, TCA-cycle and 
mitochondrial respiration. In mitochondrial respiration, electron transport by the respiratory 
protein complexes is coupled to oxidative phosphorylation yielding ATP from ADP. 
Regulation of mitochondrial metabolism and respiration is a crucial mechanism of cellular 
adaptation, e.g. in response to nutritional alterations or energy depletion. For instance, 
induction of mitochondrial biogenesis can be observed in muscle as a reaction to physical 
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exercise [14] or mitochondrial mutations [15], and is linked to the actions of AMPK, PPARs 
and PGC1α. [16]. Multiple important functions of  mitochondrial regulators have previously 
been characterised in rat liver after nutritional and pharmacological interventions [17].   
Tetradecylthioacetic acid (TTA) is a modified fatty acid that has hypolipidemic effects 
in rats [18,19]. This agent activates all the PPAR members, in the ranking order PPARα > 
PPARδ > PPARγ [19]. Treatment with TTA dramatically increases the mitochondrial 
oxidative capacity in rat hepatocytes, which seems only partly to be explained by PPAR-
activation [17,20]. Here, we used TTA-treatment to investigate the impact and mechanisms of 
mitochondrial adaptation in relation to key signalling pathways involved in metabolic 
regulation in rat hepatocytes.  
 
2. Materials and methods 
2.1. Materials 
TTA was synthesised as described previously [21]. The mtHSP70 and β-actin antibodies were 
from Abcam (Cambridge, UK), whereas the antibodies for Akt, p-Akt (S473), mTOR 4E-BP1, 
p-4E-BP1, eIF4G, p-eIF4G, ERK and p-ERK were all from Cell Signaling Technology Inc 
(Danvers, MA, USA).   
 
2.2. Animals and treatments 
The animal study was conducted according to the guidelines for the care and use of 
experimental animals, and the protocol was approved by the Norwegian State Board of 
Biological Experiments with Living Animals.  Eight to ten week old (150-200g) male Wistar 
rats were obtained from Taconic Europe (Ry, Denmark) and acclimatised for one week prior 
to experiment. Control groups were given a normal chow diet, while the TTA-treated group 
were given chow pellets sprayed with 0.3% (w/w) TTA; both groups were fed ad libitum. The 
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daily intake of TTA was estimated to 60 mg based on a consumption of 20 g of feed each day.  
For each experiment, two animals in each group were sacrificed, one for collection of biopsies 
and one for liver perfusion.  Hepatocytes were isolated using in vitro collagenase perfusion as 
previously described [22,23].  
 
2.3. Transmission electron microscopy (TEM) 
Cells and tissue biopsies were fixed in cold 0.1M Na-Cacodylate buffer, pH 7.4, containing 
2.5% glutaraldehyde for 15 min. Samples were rinsed with 0.1M Na-Cacodylate buffer for 10 
min and post-fixed in 1% osmium tetraoxide (OsO4) for 60 min. Following ethanol 
dehydration, the samples were embedded in epoxy resin. Ultra-thin sections were prepared 
and double-stained with uranyl acetate and lead citrate. Microscopy was performed on a Jeol 
JEM-1230 instrument (Jeol Ltd., Tokyo, Japan) at the Molecular Imaging Centre (University 
of Bergen). Pictures were acquired using the GATAN multiscan camera (Gatan Inc, 
Pleasanton, CA, USA).  
 
2.4. Mitochondrial respiration 
Oxygen consumption rates were analysed using Oxygraph O2K and DatLab software 
(Oroboros Instruments, Austria). The oxygen consumption rates were normalized to the 
number of cells in each chamber. Measurements in intact hepatocytes were performed in 
RPMI 1640 cell culture medium (without FBS) after sequential additions of oligomycin 
(1.8µg/ml), carbonylcyanide- 4-(trifluoromethoxy)-phenylhydrazone (FCCP) (titrated to 
maximal activity, titration range 0.1– 0.27 mM), rotenone (0.5 µM), antimycin A (2.5 µM). 
The respiration medium for permeabilised cells was 0.5 mM  EGTA, 3 mM MgCl2∙6H2O, 60 
mM K-lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM HEPES, 110 mM sucrose and 
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1 g/l bovine serum albumin. The additional supplements were malate (1.8 mM), glutamate 
(9.1 mM), succinate (9.1 mM), digitonin (3.7 µM) and ADP (2.3 mM). 
    
2.5. Citrate synthase measurements 
Citrate synthase activity was measured in 2x105 cells/ml in incubation medium as previously 
described [24].   
 
2.6. Flow cytometry 
Viable cells were analysed only for their FSC-H and SSC-H properties in a BD FACSCalibur 
flow cytometer (BD Biosciences, San Jose, CA, USA).  For protein analysis, hepatocytes 
were fixed (3.7% para-formaldehyde in PBS), permeabilised (methanol) and immunostained 
according to the protocol provided by Cell Signaling Technology Inc. Following labelling 
with Alexa Fluor 488-conjugated secondary antibody (Invitrogen, Carlsbad, CA, USA), the 
analysis was performed using an Accuri C6 flow cytometer (Accuri Cytometers Inc., Ann 
Arbor, MI, USA)  
 
2.7. RNA isolation and quantitative real-time PCR  
RNA was extracted from tissue samples using RNAeasy Mini kit (Qiagen, Hilden, Germany). 
Reverse transcription was performed using High-Capacity Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA, USA). Quantitative PCR was performed in the LightCycler 480 
detection system using the LightCycler 480 Probes master kit (Roche, Basel, Switzerland). 
The following genes were analysed using specific FAM probes and primers from Applied 
Biosystems: Cytochrome c oxidase (COX), Cox4i1,Rn00665001_g1; Cytochrome c somatic 
(Cyt c), Rn00820639_g1; Transcriptional Factor A mitochondrial (TFAM), 
Rn_00580051_m1; Carnitine palmitoyl transporter 1 (CPT-1), Rn0050702_m1; CPT-2, 
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Rn00563995_m1; Rn01495769_m1: Carnitine/acylcarnitine translocase (CACT) (Slc25a20), 
Rn00588652; Acyl-CoA oxidase-1 (ACOX-1)  , Rn00569216;  3-hydroxy-3-methylglutaryl-
CoA synthase 2 (mitochondrial) (HMGCS-2), Rn00597339: Nuclear respiratory factor 1 
(NRF-1) Rn01455958_m1; Uncoupling protein 3 (UCP3), Rn00565874_m1. For reference 
we used the 18s rRNA control kit FAM-TAMRA (RT-CKFT-18s) from Eurogentec (Liége, 
Belgium). 
 
2.8. Mitochondrial DNA quantification 
DNA was isolated from primary hepatocytes using DNA Blood and Tissue Kit (Qiagen). 
Specific primer for mitochondrial DNA (mtDNA), ND1 (Rn03296764_s1), was purchased 
from Applied Biosystems and nuclear DNA (nDNA) primer 18S (RT-CKFT-18s) from 
Eurogentec. Real-time PCR was carried out on Lightcycler 480 detection system (Roche) and 
the mtDNA/nDNA ratio was calculated [25]. 
 
2.9. Western Blots 
Protein concentrations were measured using the Thermo Scientific Pierce BCA Protein Assay 
Kit (Thermo Scientific Pierce Protein Biology, Rockford, IL, USA).  SDS-PAGE and 
Western blotting were performed using the Invitrogen system, with PVDF membranes. 
Detection was done using secondary antibody conjugated to HRP from BioRad Laboratories 
Inc (Hercules, CA, USA) and ECL Western Blotting Substrate (Thermo Scientific Pierce 
Protein Biology) in a LAS-3000 imaging system (Fujifilm, Tokyo, Japan).  Pixel analysis was 
performed using Multi Gauge V2.2. software (Fujifilm).      
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2.10. Statistical Analysis 
Three independent experiments were performed.  Data were analysed using a two sided t-test, 
and a p-value <0.05 was considered to indicate statistical significance.        
 
3. Results 
3.1. Mitochondrial biogenesis coincides with hypertrophy in hepatocytes of TTA-treated rats  
The hypolipidemic effect of TTA was first confirmed by measuring levels of 
cholesterol, triglycerides and phospholipids in blood plasma, after treating the rats for 3 weeks 
(data not shown). The TTA-treated rats had significantly larger livers (Fig. 1A), which also 
was in accordance with previous studies [26]. Hepatocytes were isolated from these livers in 
order to characterize in more detail the effects of TTA on cellular phenotype and 
mitochondrial biomass. We found that the hepatocyte protein content tended to increase, 
although the relatively large standard deviation prevented statistical significance. This was, 
however, accompanied by higher levels of the mitochondrial biomarkers mtDNA and citrate 
synthase, of which the latter demonstrated a statistically significant change (Fig 1A). 
Furthermore, flow cytometry analysis showed that cells from TTA-treated rats were larger 
(forward scatter, FSC-H), and the cellular granularity was increased (side scatter, SSC-H) (Fig. 
1B).   
The cellular morphology was investigated in more detail by transmission electron 
microscopy (Fig. 1C). In accordance with the data above (Fig 1B), hepatocytes from TTA-
treated rats were observed to be larger in size, and have a richer granular content compared to 
the control cells. Apparently, this included increased number of mitochondria and 
peroxisomes, as well as glycogen particles indicating alterations in carbohydrate metabolism. 
There were also significant changes in the morphology of rough and smooth endoplasmatic 
reticulum. Observations in isolated hepatocytes correlated with intact liver tissue.  
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In order to confirm that TTA induced mitochondrial biogenesis, we measured mRNA 
expression of several associated markers, as well as proteins involved in fatty acid 
metabolism, in samples from liver. The data demonstrated a moderate increase in two key 
proteins in mitochondrial biogenesis, NRF-1 and TFAM, as well as mRNA levels of two 
proteins of the respiratory system, COX and Cyt c (Fig. 1D).  Moreover, increased mRNA 
expression of CPT-1, CPT-2, CACT and HMGSC-1 indicated upregulation of mitochondrial 
fatty acid oxidation and ketogenesis. This was also associated with a significant increase in 
UCP3 expression, confirming previous results [27]. The upregulation of these factors, as well 
as ACOX-1, supports PPARα activation. These data confirm that TTA induces expression of 
multiple genes involved in mitochondrial biogenesis and function.  
 
3.2. Stimulated mitochondrial respiration in hepatocytes from TTA-treated rats 
In order to determine if the observed increase in mitochondrial biogenesis influenced 
mitochondrial respiratory function, we measured oxygen consumption rates.  The data 
demonstrated that the respiratory rate in RPMI cell culture medium (ROUTINE) was 
increased 2.6 fold in hepatocytes of TTA-treated rats (Fig. 2A). This change was accompanied 
by increased non-phosphorylating respiration (LEAK), when ATP synthase was inhibited 
with oligomycin. Furthermore, the capacity of the electron transport system (ETS) was 
increased 2.5 fold, measured after full uncoupling with FCCP. Interestingly, in contrast to 
control hepatocytes, a significant fraction of the respiration in intact hepatocytes from TTA-
treated rats were independent of respiratory complex I, as observed after addition of the 
complex I inhibitor rotenone (ETSrot).  These data further reveal that both TTA and control 
cells utilized about 50% of the maximum capacity (ETS) under normal cell culture conditions 
(ROUTINE). However, the larger fraction of LEAK respiration in TTA-treated rats, suggests 
that more of the respiratory activity is uncoupled from ATP synthesis.   
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In order to study the modulation of oxidative phosphorylation in more detail, we 
permeabilised the cells to allow free flux of substrates into the mitochondria (Fig. 2B).  
Consistent with the findings in intact cells, respiration in presence of malate, glutamate and 
succinate (MGS) was significantly increased after treatment with TTA. Addition of ADP 
demonstrated that there was an increase in the oxidative phosphorylation capacity (OXPHOS). 
Both the LEAK and ETS respiratory rates were higher, confirming the results in intact cells 
(Fig 2A). However, addition of rotenone had minor effect in both cell types. The 
phosphorylation system control ratio (OXPHOS/ETS) was calculated to 0.45±0.06 and 
0.81±0.18 in control and TTA-treated cells, respectively, suggesting that the limitation of 
electron flux exerted by the phosphorylation system was reduced.  
 
3.3. TTA-treatment activates mTOR signalling in rat liver 
The hypertrophic response in hepatocytes of TTA-treated rats was found to be 
accompanied by an increase in mitochondrial biomass and oxidative capacity. We further 
examined if these effects were associated with regulation of Akt, ERK1/2 and mTOR, three 
key signalling factors of cell homeostasis and adaptation. Flow cytometry analysis indicated 
that expression of mTOR was increased (Fig. 3A), and activation of this pathway was 
supported by increased phosphorylation of the downstream actors 4E-BP1 and eIF4G, as 
demonstrated by western blotting (Fig. 3B). The protein levels of these factors were also 
increased. The level of Akt was unchanged or slightly reduced, but we observed a minor 
increase in phosphorylation at Ser473 (Fig. 3A). Finally, we found that the protein level and 
phosphorylation of ERK1/2 was increased in TTA treated rats; although statistics could not be 
calculated since we only had samples from two rats in each group for this analysis (Fig. 3B).  
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4. Discussion 
This work demonstrates that the significant increase in mitochondrial oxidation 
capacity observed in rat hepatocytes after treatment with TTA can be explained by induction 
of mitochondrial biogenesis accompanied by increased mitochondrial respiration. The 
adaptive mechanism involved PPAR-activation in addition to signalling via ERK1/2 and 
mTOR, and was associated with cellular hypertrophy.  
Previous studies have demonstrated that the modified fatty acid TTA act as a pan-
PPAR activator and regulate processes of lipid and energy metabolism in animals 
[17,18,19,20] . Activation of PPARα was confirmed by upregulated mRNA expression of 
ACOX, CPT II and UCP3, representing target genes of this transcription factor [27,28]. 
Furthermore, our study showed that the increased liver weight involved cellular organelle 
amplifications, a known stress response after increased functional load in the liver [29]. The 
increase in hepatocyte cell size, granularity and protein content was consistent with cellular 
hypertrophy. Hypertrophy is a well-known effect of PPARα activation that seems restricted to 
rodents and not humans [30]. Induction of mitochondrial biogenesis was confirmed by 
measuring mtDNA, citrate synthase activity and mRNA expression of mitochondrial proteins.  
Although the morphology appeared less organized in samples from TTA-treated rats, there 
were no signs of cellular toxicity and the biochemical function was intact. Previous data from 
long term rat experiments (50 weeks)  [27] and clinical studies [31] have shown that TTA is 
well tolerated.   
 This study suggest that mTOR, possibly via interaction with ERK1/2 and Akt, may be 
involved in an adaptive stress response leading to hypertrophy and mitochondrial biogenesis 
in hepatocytes after treatment with TTA. This may share similarity with the adaptive 
signalling response of mitochondrial biogenesis observed in muscle after exercise [32]. 
Furthermore, TTA has effects in common fasting condition, including increased fatty acid 
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oxidation and ketogenesis, which have been associated with PGC1α [33],  another player in 
the mTOR network [34]. Moreover, recently mTORC1 was shown to act together with 
PPARα in the regulation of fasting-induced ketogenesis [7], whereas in adipocytes, PPARγ 
interacts with mTOR to regulate hypertrophy [35]. These findings suggest that the observed 
effects of TTA might involve crosstalk between PPARs and mTOR.    
Mitochondrial respiration was significantly increased together with induction of 
mitochondrial biogenesis in rat hepatocytes after treatment with TTA. This included increased 
capacities of the ETS as well as OXPHOS. However, whereas ADP-induced respiration 
closely balanced the ETS capacity in hepatocytes from TTA-treated rats, the ETS capacity 
exceeded the ADP-induced respiration in control hepatocytes. This suggests that the capacity 
to phosphorylate ADP to ATP is selectively strengthened in TTA-treated hepatocytes. 
Furthermore, the uncoupled respiration (LEAK) was increased after the treatment, supporting 
previous studies of fatty acid-driven respiration [20]. Whether or not this is associated with 
the significant up-regulation of UCP3 remains unclear since the role of this protein is still 
unknown. However, potential functions are related to metabolic balancing [36] as well as 
handling of reactive oxygen species (ROS) [37]. We also observed a significantly increased 
fraction of rotenone-insensitive respiration. This may be associated with the high rates of fatty 
acid β-oxidation, feeding electrons into the ubiquinone pool via the ETFP-ubiquinone 
oxidoreductase [38], thereby bypassing the rotenone sensitive complex I.  
In summary, these results suggest that the increased mitochondrial biogenesis and 
respiration in rat hepatocytes after treatment with TTA involves coordinated regulation of 
oxidative metabolism via PPARs in association with a hypertrophic response possibly 
mediated via mTOR. How these pathways may interact under these conditions is yet to be 
determined. Our results also highlight the extensive adaptability of hepatic mitochondria 
under metabolically demanding conditions.  
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Fig. 1.  Hypertrophy and mitochondrial biogenesis in hepatocytes of TTA-treated rats. (A) 
Rat livers were weighed directly after resection. Hepatocytes were isolated from parallel 
animals. Protein content and citrate synthase activity was determined in isolated hepatocytes, 
and normalized to cell number. The amount of mtDNA was measured relative to nDNA in 
liver tissue. Fold change was calculated relative to the corresponding control. The data are 
presented as mean ± S.D. of three rats, with each measurement performed in duplicate or 
triplicate. (B) Isolated hepatocytes were analysed by flow cytometry, and viable cells were 
gated from a population of 10000 cells. The histograms show representative data from 
forward and side scatter (FSC-H and SSC-H, respectively; A.U., arbitrary units). The data are 
derived from >10 measurements in both groups, in two independent experiments. (C) 
Transmission electron microscopy of isolated primary hepatocytes (left hand panel) and liver 
tissue (right hand panel). The samples were either from control (upper row) or TTA-treated 
(lower row) rats. The images are a representative selection of >20 pictures of different 
sections from two separate experiments. Indicated structures: Bile caniliculi in tissue, BC; 
glycogen, Gly; mitochondria, Mt; Mt-ph, mitophagy; peroxisomes, P; Rough endoplasmatic 
reticulum ,RER; smooth endoplasmatic reticulum, SER. (D) mRNA expression of selected 
genes in rat liver. The data represent mean ± S.D. of three rats, with each measurement 
performed in triplicate. The genes are classified based on function.   
*p<0.05 compared to control.  
 
Fig. 2.  TTA treatment induced respiration in rat hepatocytes. Mitochondrial respiration was 
measured in hepatocytes (45- 90*10^5 cells/ml) isolated from control and TTA-treated rats.  
Oxygen consumption rates were determined after sequential additions of modulators. (A) 
Basal respiration (ROUTINE) in intact cells was measured in RPMI 1640 medium. Addition 
 19 
of oligomycin (LEAK) was followed by titration with the uncoupler FCCP to give electron 
transport system capacity (ETS). Rotenone was then added (ETSrot), and finally antimycin A 
to give the background activity. The figure shows mean ± S.D. of two experiments with 
duplicate measurements.  (B) Cells were permeabilised with digitonin in respiration medium. 
The basal respiratory rate was determined in the presence of malate, glutamate and succinate 
as substrates (MGS).  ADP was then added to determine the oxidative phosphorylation 
capacity (OXPHOS).  LEAK, ETS, ETSrot and background were then determined as 
described above.  The figure shows representative data from one of three independent 
experiments, and the results are presented as mean ± S.D. of four measurements 
*p<0.05 compared to control.         
 
Fig. 3.  Effects on Akt/ERK/mTOR signaling. (A) Immunodetection by flow cytometry was 
performed to analyse the protein expression and phosphorylation status of Akt and mTOR.  
The figure shows representative histograms, and the column diagram display fold change in 
geometric mean after TTA-treatment. Data are presented as mean ± S.D, and represents two 
experiments with triplicate measurements.  (B) Western blot analysis was performed to detect 
protein expression and phosphorylation. The figure shows representative blots from three 
independent experiments with cells from three different animals. The band intensities were 
quantified and normalised to β-actin, before calculating fold change relative to control (mean 
± S.D., n=2-3).  
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